期刊
AMERICAN JOURNAL ON ADDICTIONS
卷 20, 期 1, 页码 56-62出版社
WILEY
DOI: 10.1111/j.1521-0391.2010.00095.x
关键词
-
资金
- NIDA NIH HHS [R01DA019460, R01 DA019460] Funding Source: Medline
- NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019460] Funding Source: NIH RePORTER
This study assessed counselors' knowledge of the adoption of evidence-based tobacco cessation medications (TCMs)-varenicline, bupropion, and five nicotine replacement therapies (NRTs)-and predictors of adoption in diverse substance abuse treatment settings. We used Managing Effective Relationships in Treatment Services (MERITS I) data from 658 counselors working in 26 programs. Adoption of varenicline was reported by 16% of counselors, bupropion by 11%, and NRTs by 27%. Knowledge of the adoption of all types of TCMs was more likely to be reported by counselors who worked in treatment programs that adhered less to a 12-step orientation and restricted outdoor smoking for employees. Several additional unique predictors of varenicline and NRTs were identified. (Am J Addict 2010;00: 1-7).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据